Nanocarriers for drug delivery : liposomes and polymersomes
According to the World Health Organization (WHO), glaucoma is the world’s second leading cause of blindness and it can affect anyone from any race, gender and age. Current treatment methods for glaucoma include the use of topical daily eye drops, laser therapy and surgery. Topical daily eye drop...
Saved in:
Main Author: | |
---|---|
Other Authors: | |
Format: | Final Year Project |
Language: | English |
Published: |
2016
|
Subjects: | |
Online Access: | http://hdl.handle.net/10356/66360 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Summary: | According to the World Health Organization (WHO), glaucoma is the world’s second
leading cause of blindness and it can affect anyone from any race, gender and age.
Current treatment methods for glaucoma include the use of topical daily eye drops, laser
therapy and surgery. Topical daily eye drop is often used in glaucoma treatment.
However less than 5% of the drug permeates and enters the eye due to the physiological
and anatomical of eye barriers. Hence it usually leads to suboptimal control of intraocular
pressure (IOP) and poor patient compliance.
To overcome these drawbacks, sustained drug delivery is warranted that could be
beneficial for ocular diseases such as glaucoma. In this project, liposomes and
polymersomes are synthesized as nanocarriers and its loading capability is explored and
will be evaluated in in-vitro conditions. Three different lipids are used to formulate
liposomes which are then loaded with varying concentrations of latanoprost drug. Their
size stability and release profiles are then studied and compared. Loading capability of
polymersomes is also explored using 5(6)-carboxyfluorescein (CF) dye. The size and
morphology of the CF-loaded polymersomes as well as its release profile are studied.
Liposomes have shown promising results for sustained delivery while more studies are
require to determine and understand the optimal conditions for loading and sustained
drug delivery using polymersomes. |
---|